Evidence map›Paper›PMID 27668656›Full record

ArticleNature genetics2016

TSHZ3 deletion causes an autism syndrome and defects in cortical projection neurons.

Xavier Caubit, Paolo Gubellini, Joris Andrieux, Pierre L Roubertoux, Mehdi Metwaly, Bernard Jacq, Ahmed Fatmi, Laurence Had-Aissouni, Kenneth Y Kwan, Pascal Salin and 19 more

Open access · greenAbstract read
In one paragraph

Article in Nature genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
15.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 142 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Derepression of transposable elements in the mouse prefrontal cortex disrupts social behavior.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. HumaneLife · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 13 institutions in 5 countries.

Xavier Caubit *Aix Marseille Univ, CNRS, IBDM, Marseille, France.
Paolo GubelliniAix Marseille Univ, CNRS, IBDM, Marseille, France.
Joris AndrieuxInstitut de génétique médicale, Hôpital Jeanne de Flandre, CHRU Lille, France.
Pierre L RoubertouxAix Marseille Univ, INSERM, GMGF, Marseille, France.
Mehdi MetwalyAix Marseille Univ, CNRS, IBDM, Marseille, France.
Bernard JacqAix Marseille Univ, CNRS, IBDM, Marseille, France.
Ahmed FatmiAix Marseille Univ, CNRS, IBDM, Marseille, France.
Laurence Had-AissouniAix Marseille Univ, CNRS, IBDM, Marseille, France.
Kenneth Y KwanDepartment of Neuroscience, Yale School of Medicine, New Haven, CT, USA.
Pascal SalinAix Marseille Univ, CNRS, IBDM, Marseille, France.
Michèle CarlierAix Marseille Univ, CNRS, LPC, Marseille, France.
Agne LiedénKarolinska University Hospital Solna, Clinical Genetics Unit, Stockholm, Sweden.
Eva RuddKarolinska University Hospital Solna, Clinical Genetics Unit, Stockholm, Sweden.
Marwan ShinawiDepartment of Pediatrics, Division of Genetics and Genomic Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Catherine Vincent-DelormeService de Génétique clinique, Hôpital Jeanne de Flandre, CHRU Lille, France.
Jean-Marie CuissetService de Neuropédiatrie, Hôpital Salengro, CHRU Lille, France.
Marie-Pierre LemaitreService de Neuropédiatrie, Hôpital Salengro, CHRU Lille, France.
Fatimetou AbderrehamaneInstitut de génétique médicale, Hôpital Jeanne de Flandre, CHRU Lille, France.
Bénédicte DubanCentre de cytogénétique, Hôpital Saint Vincent de Paul, GHICL, UCL, Lille, France.
Jean-François LemaitreCentre de cytogénétique, Hôpital Saint Vincent de Paul, GHICL, UCL, Lille, France.
Adrian S WoolfInstitute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, Manchester Academic Health Science Centre and the Royal Manchester Children's and St Mary's Hospitals, Manchester, UK.
Detlef BockenhauerUCL Institute of Child Health, London, UK.
Dany SeveracMGX-Montpellier GenomiX, c/o Institut de Génomique Fonctionnelle, Montpellier, France.
Emeric DuboisMGX-Montpellier GenomiX, c/o Institut de Génomique Fonctionnelle, Montpellier, France.
Ying ZhuDepartment of Neuroscience, Yale School of Medicine, New Haven, CT, USA.
Nenad SestanDepartment of Neuroscience, Yale School of Medicine, New Haven, CT, USA.
Alistair N GarrattInstitute of Cell Biology and Neurobiology, Center for Anatomy, Charité University Hospital Berlin, Berlin, Germany.
Goff Lydia Kerkerian-Le *Aix Marseille Univ, CNRS, IBDM, Marseille, France.
Laurent FasanoAix Marseille Univ, CNRS, IBDM, Marseille, France.
Centre National de la Recherche Scientifique · FRHôpital Jeanne de Flandre · FRGroupe Hospitalier de l'Institut Catholique de Lille · FRHôpital Roger Salengro · FRKarolinska University Hospital · SEMontpellier GenomiX · FRYale University · USCharité - Universitätsmedizin Berlin · DEInserm · FRManchester Academic Health Science Centre · GBUniversity College London · GBUniversity of Michigan · USWashington University in St. Louis · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Functional Genomics of Human Brain DevelopmentP50MH106934 · NIMH · YALE UNIVERSITY · PI SESTAN, NENAD · 2014 to 2019
$7.9M
Transcriptional and Epigenetic Signatures of Human Brain Development and AutismU01MH103339 · NIMH · YALE UNIVERSITY · PI SESTAN, NENAD, STATE, MATTHEW W. · 2014 to 2017
$6.5M
2/2 Somatic mosaicism and autism spectrum disorderU01MH106874 · NIMH · YALE UNIVERSITY · PI SESTAN, NENAD · 2015 to 2019
$4.0M
Medical Research Council MR/L002744/1NCATS NIH HHS UL1 TR001863NIMH NIH HHS P50 MH106934NIMH NIH HHS U01 MH103339NIMH NIH HHS U01 MH106874
6 · The paper itself

Abstract

TSHZ3, which encodes a zinc-finger transcription factor, was recently positioned as a hub gene in a module of the genes with the highest expression in the developing human neocortex, but its functions remained unknown. Here we identify TSHZ3 as the critical region for a syndrome associated with heterozygous deletions at 19q12-q13.11, which includes autism spectrum disorder (ASD). In Tshz3-null mice, differentially expressed genes include layer-specific markers of cerebral cortical projection neurons (CPNs), and the human orthologs of these genes are strongly associated with ASD. Furthermore, mice heterozygous for Tshz3 show functional changes at synapses established by CPNs and exhibit core ASD-like behavioral abnormalities. These findings highlight essential roles for Tshz3 in CPN development and function, whose alterations can account for ASD in the newly defined TSHZ3 deletion syndrome.

Indexed as

AnimalsAutism Spectrum DisorderChromosome DeletionChromosomes, Human, Pair 19FemaleGene DeletionGene Expression Regulation, DevelopmentalHaploinsufficiencyHeterozygoteHomeodomain ProteinsHumansMaleMiceMice, Inbred CBANeocortexNeurogenesisHomeodomain ProteinsTeashirt 3 protein, mouseTranscription FactorsTSHZ3 protein, human

Identifiers

PMID27668656
PMCPMC5083212
OpenAlexW2526124160

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.